Discontinued — last reported Q3 '21
Cencora Pharmaceutical Distribution Services — CapEx remained flat by 0.0% to $65.55M in Q3 2021 compared to the prior quarter.
Higher spending indicates investment in future capacity and efficiency, while lower spending may signal cost-cutting or maturity.
The cash spent by the pharmaceutical distribution segment to acquire, upgrade, or maintain physical assets such as distr...
Comparable to the infrastructure investment levels of other major pharmaceutical distributors.
cor_segment_pharmaceutical_distribution_services_capital_expenditures| FY'21 | |
|---|---|
| Value | $262.20M |